EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 337 filers reported holding EXELIXIS INC in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $283 | – | 13 | -13.3% | 0.00% | – |
| Q2 2022 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 15 | -98.2% | 0.00% | -100.0% |
| Q1 2020 | $15,000 | 0.0% | 849 | 0.0% | 0.00% | +50.0% |
| Q4 2019 | $15,000 | 0.0% | 849 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $15,000 | -16.7% | 849 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $18,000 | -18.2% | 849 | -7.2% | 0.00% | -40.0% |
| Q1 2019 | $22,000 | +22.2% | 915 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $18,000 | +12.5% | 915 | 0.0% | 0.01% | +25.0% |
| Q3 2018 | $16,000 | -56.8% | 915 | -46.5% | 0.00% | -55.6% |
| Q2 2018 | $37,000 | – | 1,710 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
| NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
| GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
| Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
| Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
| Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
| BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
| CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
| TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |